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Oral hygiene grade and quality of
life in children with chemotherapy-
related oral mucositis: a randomized
study on the impact of a fluoride
toothpaste with salivary enzymes,
essential oils, proteins and colostrum
extract versus a fluoride toothpaste
without menthol
Abstract: Aim: The aim of this study was to assess the impact of the
use of a fluoride toothpaste (Bioxtra!, Biopharm, Milan, Italy) with
salivary enzymes, essential oils, proteins and colostrum extract versus
a fluoride toothpaste without menthol on the oral hygiene grade and on
the quality of life (QoL) of children with oral mucositis (OM) grade 1 or
2 receiving chemotherapy for Acute Lymphoblastic Leukaemia (ALL).
Methods: Patients between 6 and 14 years with OM were randomly
assigned to two groups, group A (Bioxtra! toothpaste) and group B
(fluoride toothpaste without menthol). The patients were instructed to
brush their teeth at least twice a day using a soft toothbrush with a
small head. Oral hygiene grade was assessed using the simplified oral
hygiene index (OHI-s); quality of life was assessed using the short
form of the Oral Health Impact Profile (OHIP-14) questionnaires. The
patients were evaluated on day 1(diagnosis of OM-T0) and on day 8
(T1). Statistical analysis was performed. Results: A total of 64 patients
were enrolled. A significant difference (P < 0.001) between the mean
of the OHI-s in group A (0.9 ! 1.2) and in group B (1.5 ! 1.3) was
found; the overall OHIP-14 scores were not associated with the use of
one or the other toothpaste (P = 0.33). Conclusions: Although the use
of Bioxtra! toothpaste does not affect the QoL of children undergoing
chemotherapy, it may be recommended as clinically effective in
improving the oral hygiene grade.
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Introduction
Children undergoing chemotherapy often present various psychological,
physical and emotional changes that could impair their quality of life
(QoL). Among the oral complications, chemotherapy-induced oral
mucositis (OM) is the most debilitating and problematic side effect
(1, 2). OM associated with immunosuppression can lead to serious and
potentially life-threatening consequences interfering with the treatment
and with patients’ QoL (1, 2).
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Management of oral mucositis has been largely palliative to
date, although targeted therapeutic interventions are now
being developed. Based on a comprehensive systematic review
of the literature, the Mucositis Study Group of the Multina-
tional Association for Supportive Care in Cancer and the Inter-
national Society of Oral Oncology (MASCC/ISOO) has
developed clinical practice guidelines for the management of
mucositis, divided into: nutritional support, pain control, oral
decontamination, palliation of dry mouth, management of oral
bleeding and therapeutic interventions for oral mucositis (3).
As regards oral decontamination, the MASCC/ISOO guidelines
recommend using a standardized oral care protocol which
includes brushing with a soft toothbrush, flossing and the use
of non-medicated rinses (e.g. saline or sodium bicarbonate
rinses). Patients and caregivers should be educated as regards
the importance of effective oral hygiene (4–6).
The mechanisms through which various basic oral care strate-
gies may directly influence the pathogenesis of OM are unclear,
although most have little potential for affecting the complex
interplay of molecular factors that lead to mucosal tissue injury
(4–6). First, it has been hypothesized that microbial colonization
of oral mucositis lesions exacerbates the severity of oral
mucositis and therefore, decontamination may help to reduce
mucositis, promoting an oral environment that reduces the poten-
tial for, or retards the development of, oral infection. Indeed, mul-
tiple studies have demonstrated that maintenance of good oral
hygiene can reduce the severity of oral mucositis (4–6).
In children with OM, the use of the most common tooth-
pastes is frequently suspended as it becomes intolerable for
patients with inflamed oral mucosa, often suffering also from
dysgeusia and xerostomia. The discomfort is mainly due to the
irritant components of most commercial toothpastes, such as
abrasives, surfactants, flavourings, antibacterial agents, etc.
Avoiding the use of toothpaste, of course, the efficacy of the
daily oral hygiene is reduced, increasing the risk of infections.
(2–6). Mild toothpastes without menthol – which is a cyclic
monoterpene alcohol with well-known cooling and irritating
characteristics " have been introduced onto the market
because they can be used during homeopathic treatment but
no specific toothpaste for oral mucositis is currently available.
Recently, a specific toothpaste with fluoride, salivary
enzymes, essential oils, proteins and colostrum extract has
been proposed for oral mucositis, especially in the case of
xerostomia.
The aim of this study was to evaluate the impact of Biox-
tra! (Biopharm, Milan) toothpaste versus a fluoride toothpaste
without menthol on the oral hygiene grade and on the QoL in
children with OM receiving chemotherapy for Acute Lym-
phoblastic Leukemia.
Study population and methodology
Sample selection
Children hospitalized in the Paediatric Oncology Unit of Spe-
dali Civili of Brescia (Italy) between November 2013 and
March 2015 receiving chemotherapy for Acute Lymphoblastic
Leukemia (undergoing ALL 2009 Standard protocol) and with
OM grade 1 or 2 were considered eligible for this study.
Treatment for ALL 2009 consists of an induction phase (com-
binations of four-five drugs including vincristine, prednisone,
cyclophosphamide, doxorubicin and L-asparaginase), a intensi-
fication/consolidation phase with multiagent therapy (including
cytarabine, methotrexate, cyclophosphamide, etoposide, mitox-
antrone, asparaginase, doxorubicin, 6-MP, 6-thiouguanine and
vincristine) and a maintenance therapy (including 6-mercapto-
purine and methotrexate).
Enrolment criteria were: patients aged between 6 and
14 years with ALL undergoing any one of the phases of the
chemotherapy protocol and with OM grade 1 or 2. Exclusion
criteria were: other hematologic malignancies than ALL, no
mucosal lesions or OM grade >2, hypersensitivity or allergy to
any of the components included in the study.
Study design
This study was designed as a randomized, controlled and dou-
ble-blinded clinical study. Randomization was performed using
an automatically generated list in a 1:1 block size for two
patients. Patients received a number after inclusion and they
were randomly assigned to one of the two toothpastes by a
member of the team who performed a permuted-block ran-
domization of the participants. Patients codes where inserted
in closed envelopes.
The patients were randomized by the computer code in two
groups: group A (Bioxtra! toothpaste) and group B (fluoride
toothpaste without menthol). The two toothpastes were compa-
rable, both being devoid of components irritant to the oral
mucosa. In detail, Bioxtra! toothpaste was composed of
lysozyme, lactoferrin, lactoperoxidase, colostrum purified stan-
dardized extract, sorbitol, xylitol, isoceteth-20, sodium monoflu-
orophosphate, hydroxyethylcellulose, sodium benzoate and
titanium dioxide; the fluoride toothpaste without menthol was
composed of aqua, sorbitol, hydrated silica, hydroxyethylcellu-
lose, olaflur, titanium dioxide, aroma, limonene and saccharin.
The two products were identical as regards packaging. The
patients and their caregivers were instructed to brush at least
twice a day using a soft toothbrush with a small head and a
roll-on technique. The roll-on technique was chosen as it is
easier to learn and less time-consuming, as compared to other
complex tooth brushing techniques. A pamphlet containing
pictures depicting the correct method of tooth brushing and
instructions for the parents was printed; the instructions
included the use of a pea-sized amount of the toothpaste and
the method of cleaning and storage of the toothbrush. On the
overleaf of the pamphlet, a planner was given in which the
children were asked to put a tick whenever they brushed their
teeth. Each child was given a new toothbrush and toothpaste
at the beginning of the study. Both patients and researchers
were blinded throughout the study.
Oral mucositis scoring was performed at the onset of OM in
order to exclusively select patients with OM grade 1 or 2. The
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clinical evaluation of the severity of OM was conducted in
both groups in accordance with the World health Organization
(WHO). Lesions were classified as Grade 0 = none; Grade
1 = soreness and erythema; Grade 2 = erythema and ulcers
without difficulties in swallowing solid food; Grade 3 = ulcers
requiring only a liquid diet and Grade 4 = introduction of
parental nutrition.
QoL measurements
A single member of the Paediatric Dentistry Department,
blind to toothpaste assignation, administered by interview the
QoL questionnaire to the patients in both groups on the first
day of diagnosis of OM (T0) and after 8 days (T1); the
researcher was blinded for the randomization allocation.
The short form of the Oral Health Impact Profile (OHIP-
14) questionnaire was used to evaluate QoL in relation to oral
health. The instrument has been already validated for Italian
(7). OHIP-14 summarizes the following seven domains of
impact on daily activities as a result of oral problems: func-
tional limitation (domain 1), physical pain (domain 2), psycho-
logical discomfort (domain 3), physical activity (domain 4),
psychological disability (domain 5), social disability (domain 6)
and handicap or disability (domain 7).
The OHIP-14 instrument consists of 14 questions related to
oral health, whose response options are five: 0 = never,
1 = hardly ever, 2 = occasionally, 3 = fairly often, 4 = very
often. The final score is the sum of the individual scores, with
higher values indicating worse OH-QoL; the maximum possi-
ble score is 56.
Oral hygiene
As the children were hospitalized, the clinical assessment of
the oral hygiene grade was done by two calibrated researchers
(EB, FA) according to the criteria of a simplified oral hygiene
index (OHI-s) by Greene and Vermillion with a mouth mirror
and explorer (8), on the first day of diagnosis of OM (T0) and
after 8 days (T1).
Statistical analysis
OHI-s index was evaluated using split-plot analysis of variance
(ANOVA); the differences in the OHIP-14 were analysed using
the Wilcoxon rank sum test. A 5% significance level was used
for the analysis. Taking the hypothesis that there is a success
percentage of 80% on day eight for the group treated by Biox-
tra and 45% for the control group, the minimum number of
patients for the study, assuming alpha 0.05 and beta 0.10
(study power=90%), was calculated to be 56 (at least 28 per
group).
Ethical considerations
The research was performed in compliance with the Declara-
tion of Helsinki and Good Clinical Practice. All patients and
their caregivers were informed about the research and signed
an IRB approved informed consent. Ethical approval for the
research was granted by the Ethic Committee (NP 1811
AOBS) of Spedali Civili di Brescia, Italy.
Results
Characteristics of patients
Among 108 patients affected by ALL, a total of 64 patients
(41 females and 23 males) met the inclusion criteria and were
accepted to participate in the study (Fig. 1). They were ran-
domly assigned to two groups: group A (n = 32) and group B
(n = 32). Mean age of the total sample was 8 ! 1.8 years.
There was no difference (P > 0.05) between the clinical and
demographic characteristics of the two groups, which resulted
homogeneous. The groups were homogeneous also for OM
grade (P = 0.73) (Table 1).
Clinical evaluation of OHI-s
While at T0 no differences in the mean of OHI-s were
observed between group A and group B, at T1 a significant
difference (P < 0.001) between the mean of the OHI-s in
group A (0.9 ! 1.2) and in group B (1.5 ! 1.3) was found
(Table 2).
Quality of life
The statistical analysis showed that the use of Bioxtra !was
not associated with total scores for the OHIP-14 (P = 0.33).
Therefore, the use of one or the other toothpaste did not influ-
ence patients’ QoL. The highest scores, indicating poor QoL,
were found on day +8, indicating a progressive deterioration in
QoL (Table 2).
Discussion
The major finding in this study is that the use of a specific
toothpaste such as Bioxtra ! in children with OM grade 1 or
2, despite not having a substantial a substantial impact on
their QoL, significantly affects the grade of oral hygiene. We
evaluated QoL using the OHIP-14 scale, which is not
designed to evaluate QoL in general, but specifically related
to oral health, so that the effect of confounding factors is
reduced. No patient refused to answer the survey. All partici-
pants were selected in order to have OM grade 1 or 2. In
fact, according to the Literature (9, 10) patients with OM
grade 1 or 2 should brush their teeth with a soft toothbrush
and fluoride toothpaste while patients with OM grade >2
may clean the oral cavity with a gauze or oral sponge if they
cannot use the toothbrush. Unexpectedly, most patients
(n = 19) of group B reported not having brushed their teeth
for at least for two consecutive days, due to pain and burning
while all the patients belonging to group A managed to brush
every day.
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We did not exclude these children from the control group
(even if they had not fully adhered to the oral hygiene instruc-
tion) because of the high number of patients in respect to the
study group, which must be interpreted as a significant differ-
ence in the tolerability between the two toothpastes
(P < 0.05). The clinical evaluation of the oral hygiene grade
revealed that children using a toothpaste with salivary
enzymes, essential oils, proteins and colostrum extract had a
significantly lower OHI-s. This could be attributed to the
greater tolerance of this toothpaste allowing greater accuracy
and more time spent on oral hygiene, accompanied by the
antibacterial properties of the toothpaste obtained from the
extract of colostrum. The high nutritive value and diverse
functional properties of milk proteins are well known. Such
proteins are found in abundance in colostrum which is the ini-
tial milk secreted by mammalian species during late pregnancy
and the first few days after birth of the offspring (11). The
colostrum-based bioactive proteins include alpha-lactalbumin,
beta-lactoglobulin, immunoglobulins, lactoferrin, lactoperoxi-
dase and growth factors. These native proteins exhibit a wide
range of biological activities that are known to affect the diges-
tive function, metabolic responses to absorbed nutrients,
growth and development of organs and disease resistance (12).
Of great importance for the oral cavity, enzymes are key com-
ponents of the acquired pellicle with high relevance to its pro-
tective properties (12, 13). This applies especially to the
antibacterial lysozyme and to peroxidases preventing oxidative
stress in the oral cavity by hydrolysis of peroxides and radicals
(13, 14). Lactoperoxidase from cow’s milk and lysozyme from
hen’s egg white are cheap and rather similar to their counter-
parts in human saliva (15). Thus, they are typical ingredients
ENROLLMENT
Pa!ents with ALL from November 
2013 to March 2015 (n = 108).
Pa!ents with OM (n = 86)
Excluded (n = 22).  
Pa!ents without OM.
Analysed (n = 64)
Excluded from analysis 
(not signed informed 
consent) (n = 2)
Excluded from analysis 
(worsening health 
condi!on) (n = 3)
Pa!ents with OM
grade 1 or 2 (n = 69)
Group A (n = 32) Group B (n = 32)
Randomly divided
Excluded (n = 17).  Pa!ents 
with OM grade 3 and  4.
Fig. 1. Enrolment flow-chart.
Table 1. Demographic and clinical characteristics of the
patients
Group
A(n = 32)
Group
B (n = 32) Total (n = 64)
Male:Female 13:19 10:22 23:41
Mean age
(range)
8 ! 1.9 (6–14) 8 ! 1.4 (6–14) 8 ! 1.8 (6–14)
OM score
(median)
1.5 1.5 1.5
Mean!SD
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of enzymatic oral health care compounds (12, 15). Tooth
brushing allows direct interaction of the enzymatic compounds
of the toothpaste with the pellicle layer for facilitated immobi-
lization of enzymes. In contrast to enzymatic mouth rinses,
enzymatic toothpaste has been found suitable for targeted
immobilization of enzymes in the acquired pellicle. The
brushing ensured direct contact of the enzymatic slurry with
the pellicle and supplied the respective enzymes immediately
when the pellicle was re-established after removal of the outer
layers of the pellicle (12, 15).
The pathogenesis of chemotherapy-induced OM appears to
be related to oxidative stress induced by the treatment. The
reactive oxygen species (ROS) cause direct and indirect dam-
age through transcription factors, which induce the production
of pro-inflammatory cytokines (16, 17). Therefore, the major
tolerability of Bioxtra! in the case of OM can be attributed
also to a mild anti-inflammatory effect due to the antioxidant
components.
Bio-inspired and biomimetic strategies are of considerable
interest for oral health care to avoid disturbance of the ecologi-
cal equilibrium in the oral cavity, especially in conditions such
as OM in which the respect of the oral mucosa is desirable.
Although not affecting the QoL of children undergoing
chemotherapy, the use of Bioxtra! toothpaste may be recom-
mended in these patients as clinically effective in improving
the oral hygiene grade.
Clinical relevance
Scientiﬁc rationale for study
Oral decontamination represents a prime factor in the manage-
ment of chemotherapy-induced oral mucositis in children. The
use of the most common toothpastes, in these children, is fre-
quently avoided, as it is intolerable for the inflamed oral
mucosa. This study evaluated the effectiveness of toothpaste
with salivary enzymes, essential oils, proteins and colostrum
extract both in terms of the effects on the oral hygiene grade
and on the quality of life of these patients.
Principal ﬁndings
Children with oral mucositis showed a significantly increased
oral hygiene grade when using Bioxtra! toothpaste. On the
contrary, their quality of life resulted not significantly
influenced.
Practical implications
The use of Bioxtra! toothpaste may be recommended in
onco-hematologic paediatric patients suffering from oral
mucositis.
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